(Q46862981)

25 December 2017

title

Circulating levels of markers of inflammation and endothelial activation are increased in men with chronic spinal cord injury (English)

1 reference

25 December 2017

author

Ta-chen Su

4

1 reference

25 December 2017

author name string

Tzung-Dau Wang

1

1 reference

25 December 2017

Yen-Ho Wang

2

1 reference

25 December 2017

Tien-Shang Huang

3

1 reference

25 December 2017

Shin-Liang Pan

5

1 reference

25 December 2017

Ssu-Yuan Chen

6

1 reference

25 December 2017

publication date

1 November 2007

1 reference

25 December 2017

Journal of the Formosan Medical Association

published in

1 reference

25 December 2017

volume

106

1 reference

25 December 2017

issue

11

1 reference

25 December 2017

page(s)

919-928

1 reference

25 December 2017

Cardiovascular alterations after spinal cord injury: an overview

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2808%2960062-5

7 January 2021

Mortality, morbidity, and psychosocial outcomes of persons spinal cord injured more than 20 years ago

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2808%2960062-5

7 January 2021

Tomographic thallium-201 myocardial perfusion imaging after intravenous dipyridamole in asymptomatic subjects with quadriplegia

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2808%2960062-5

7 January 2021

Inflammatory biomarkers in acute coronary syndromes: part II: acute-phase reactants and biomarkers of endothelial cell activation

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2808%2960062-5

7 January 2021

Inflammation in atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2808%2960062-5

7 January 2021

New Markers of Inflammation and Endothelial Cell Activation

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2808%2960062-5

7 January 2021

Fitness, inflammation, and the metabolic syndrome in men with paraplegia.

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2808%2960062-5

7 January 2021

Inflammatory C-reactive protein and cytokine levels in asymptomatic people with chronic spinal cord injury

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2808%2960062-5

7 January 2021

Circulating levels of IL-2R, ICAM-1, and IL-6 in spinal cord injuries

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2808%2960062-5

7 January 2021

Serial concentrations of C-reactive protein as an indicator of urinary tract infection in patients with spinal injury

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2808%2960062-5

7 January 2021

CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: report from the laboratory science discussion group

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2808%2960062-5

7 January 2021

International Standards for Neurological and Functional Classification of Spinal Cord Injury. American Spinal Injury Association

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2808%2960062-5

7 January 2021

Efficacy of cholesterol levels and ratios in predicting future coronary heart disease in a Chinese population

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2808%2960062-5

7 January 2021

Relation of improvement in endothelium-dependent flow-mediated vasodilation after rosiglitazone to changes in asymmetric dimethylarginine, endothelin-1, and C-reactive protein in nondiabetic patients with the metabolic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2808%2960062-5

7 January 2021

Decline in muscle mass with age in women: a longitudinal study using an indirect measure

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2808%2960062-5

7 January 2021

Production of C-reactive protein and risk of coronary events in stable and unstable angina. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2808%2960062-5

7 January 2021

Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2808%2960062-5

7 January 2021

Effects of tirofiban and statins on high-sensitivity C-reactive protein, interleukin-6, and soluble CD40 ligand following percutaneous coronary interventions in patients with stable coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2808%2960062-5

7 January 2021

Effect of atorvastatin on risk of recurrent cardiovascular events after an acute coronary syndrome associated with high soluble CD40 ligand in the Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) Study

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2808%2960062-5

7 January 2021

Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS).

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2808%2960062-5

7 January 2021

Factors influencing body composition in persons with spinal cord injury: a cross-sectional study

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2808%2960062-5

7 January 2021

High serum high-sensitivity C-reactive protein concentrations are associated with relative cardiac sympathetic overactivity during the early morning period in type 2 diabetic patients with metabolic syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2808%2960062-5

7 January 2021

Relation of heart rate variability to serum levels of C-reactive protein in patients with unstable angina pectoris

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2808%2960062-5

7 January 2021

Cardiovascular consequences of loss of supraspinal control of the sympathetic nervous system after spinal cord injury

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2808%2960062-5

7 January 2021

Endothelin: beyond a vasoconstrictor

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2808%2960062-5

7 January 2021

A novel potent vasoconstrictor peptide produced by vascular endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2808%2960062-5

7 January 2021

Relationship between endothelin-1 concentration and metabolic alterations typical of the insulin resistance syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2808%2960062-5

7 January 2021

Body weight and glucose metabolism have a different effect on circulating levels of ICAM-1, E-selectin, and endothelin-1 in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2808%2960062-5

7 January 2021

Levels of soluble adhesion molecules in various clinical presentations of coronary atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2808%2960062-5

7 January 2021

Cellular adhesion molecules and their relationship with measures of obesity and metabolic syndrome in a multiethnic population.

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2808%2960062-5

7 January 2021

ETA receptor mediates altered leukocyte-endothelial cell interaction and adhesion molecules expression in DOCA-salt rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2808%2960062-5

7 January 2021

Inflammatory markers and the metabolic syndrome: insights from therapeutic interventions

1 reference

https://api.crossref.org/works/10.1016%2FS0929-6646%2808%2960062-5

7 January 2021

10.1016/S0929-6646(08)60062-5

Identifiers

DOI

1 reference

25 December 2017

1 reference

25 December 2017